(Stroke. 1996;27:1553-1557.)
© 1996 American Heart Association, Inc.
Articles |
Serial Measurement of Interleukin-6, Transforming Growth Factor-ß, and S-100 Protein in Patients With Acute Stroke
the Departments of Neurology (J.S.K., S.S.Y.) and Nuclear Medicine (J.S.R.), University of Ulsan, Asan Medical Center; and the Asan Life Science Institute (J.S.K., Y.H.K), Seoul, South Korea.
Correspondence to Jong S. Kim, MD, Department of Neurology, Asan Medical Center, Song-Pa PO Box 145, Seoul 138-600, South Korea.
Background and Purpose Cytokine changes in patients with acute stroke have been insufficiently studied. The purpose of this study was to delineate the characteristics of serial changes of serum interleukin-6 (IL-6) and transforming growth factor-ß (TGF-ß) in patients with cerebral infarction and intracerebral hemorrhage.
Methods We serially (within 24 hours, at day 3, and at day 7) measured the serum levels of IL-6 and TGF-ß in 29 patients with acute stroke (10 with large cortical cerebral infarction, 9 with subcortical small infarction, and 10 with intracerebral hemorrhage). As an index of brain damage, S-100 protein was also measured. Twelve age-matched healthy subjects were tested as a control.
Results S-100 protein was detected in only 11 patients with large infarction or intracerebral hemorrhage. Its level peaked at day 3 in patients with infarction, whereas it peaked within 24 hours in those with intracerebral hemorrhage. The level of IL-6 was most markedly elevated at day 1, which tended to decrease thereafter. However, its level remained significantly elevated compared with that of the control group even at day 7. The level of TGF-ß was significantly decreased at day 1 and day 3 and tended to return toward the control value thereafter. The levels of both cytokines were not significantly different among the three different stroke subtypes and were not correlated with the number of blood leukocytes and platelets.
Conclusions The alteration of IL-6 and TGF-ß levels, which occurs rapidly after acute stroke regardless of the subtype, may reflect the changing immunological-inflammatory status of these patients and does not appear to reflect merely the consequence of the brain damage.
Key Words: cytokines • interleukins • stroke • transforming growth factors
This article has been cited by other articles:
 |
|
 |
|
  D. Yururer, S. Teber, G. Deda, Y. Egin, and N. Akar The Relation Between Cytokines, Soluble Endothelial Protein C Receptor, and Factor VIII Levels in Turkish Pediatric Stroke Patients Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 545 - 551. [Abstract] [PDF]
|
|
|
|
 |
|
 T Molnar, A Peterfalvi, L Szereday, G Pusch, L Szapary, S Komoly, L Bogar, and Z Illes Deficient leucocyte antisedimentation is related to post-stroke infections and outcome J. Clin. Pathol., November 1, 2008; 61(11): 1209 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Tso, J. G. Merino, and S. Warach Interleukin-6 174G/C Polymorphism and Ischemic Stroke: A Systematic Review Stroke, November 1, 2007; 38(11): 3070 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Luo, A. H. Lin, E. Masliah, and T. Wyss-Coray Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration PNAS, November 28, 2006; 103(48): 18326 - 18331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Foerch, O. C. Singer, T. Neumann-Haefelin, R. du Mesnil de Rochemont, H. Steinmetz, and M. Sitzer Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery Infarction Arch Neurol, July 1, 2005; 62(7): 1130 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Motallebzadeh, R. Kanagasabay, M. Bland, J. C. Kaski, and M. Jahangiri S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lynch, R. Blessing, W. D. White, H. P. Grocott, M. F. Newman, and D. T. Laskowitz Novel Diagnostic Test for Acute Stroke Stroke, January 1, 2004; 35(1): 57 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mathew, H. P. Grocott, B. Phillips-Bute, M. Stafford-Smith, D. T. Laskowitz, D. Rossignol, J. A. Blumenthal, and M. F. Newman Lower Endotoxin Immunity Predicts Increased Cognitive Dysfunction in Elderly Patients After Cardiac Surgery Stroke, February 1, 2003; 34(2): 508 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Elting, G. A. Sulter, M. Kaste, K. R. Lees, H. C. Diener, M. Hommel, M. Versavel, A. W. Teelken, and J. De Keyser AMPA Antagonist ZK200775 in Patients With Acute Ischemic Stroke: Possible Glial Cell Toxicity Detected by Monitoring of S-100B Serum Levels Stroke, December 1, 2002; 33(12): 2813 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jordan, J. Hagedohm, J. Wiltfang, G. Laier-Groeneveld, H. Tumani, A. Rodenbeck, E. Ruther, and G. Hajak Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Eur. Respir. J., July 1, 2002; 20(1): 158 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Gartner, W. Lang, F. Leutmetzer, H. Domanovits, W. Waldhausl, and L. Wagner Cerebral Expression and Serum Detectability of Secretagogin, a Recently Cloned EF-hand Ca2+ -binding Protein Cereb Cortex, December 1, 2001; 11(12): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Bottiger, S. Mobes, R. Glatzer, H. Bauer, A. Gries, P. Bartsch, J. Motsch, and E. Martin Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in Humans Circulation, June 5, 2001; 103(22): 2694 - 2698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gunsilius, A. L. Petzer, G. Stockhammer, C. M. Kahler, G. Gastl, and M. Slevin Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 in Serum of Patients With Acute Ischemic Stroke Response Stroke, January 1, 2001; 32 (1): 275 - 278. [Full Text] [PDF]
|
|
|
|
|
|
M. Herrmann, P. Vos, M. T. Wunderlich, C. H. M. M. de Bruijn, and K. J. B. Lamers Release of Glial Tissue-Specific Proteins After Acute Stroke : A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein Stroke, November 1, 2000; 31(11): 2670 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vila, J. Castillo, A. Davalos, and A. Chamorro Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke Stroke, October 1, 2000; 31(10): 2325 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik, and J. Gaffney Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 in Serum of Patients With Acute Ischemic Stroke Stroke, August 1, 2000; 31(8): 1863 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Westaby, K. Saatvedt, S. White, T. Katsumata, W. van Oeveren, N. K. Bhatnagar, S. Brown, and P. W. Halligan IS THERE A RELATIONSHIP BETWEEN SERUM S-100{beta} PROTEIN AND NEUROPSYCHOLOGIC DYSFUNCTION AFTER CARDIOPULMONARY BYPASS? J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Bokesch Breaking down the blood-brain barrier Ann. Thorac. Surg., December 1, 1999; 68(6): 2013 - 2014. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, A. Chamczuk, Y. Hong, and G. Jackowski Rapid and Sensitive Immunoassay for the Measurement of Serum S100B Using Isoform-specific Monoclonal Antibody Clin. Chem., August 1, 1999; 45(8): 1307 - 1311. [Full Text] [PDF]
|
|
|
|
|
|
M. T. Wunderlich, A. D. Ebert, T. Kratz, M. Goertler, S. Jost, and M. Herrmann Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain Damage Stroke, June 1, 1999; 30(6): 1190 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raabe, D. K Menon, S. Gupta, M. Czosnyka, and J. D Pickard Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study J. Neurol. Neurosurg. Psychiatry, December 1, 1998; 65(6): 930 - 932. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rosen, L. Rosengren, J. Herlitz, and C. Blomstrand Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage After Cardiac Arrest Stroke, February 1, 1998; 29(2): 473 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Missler, M. Wiesmann, C. Friedrich, and M. Kaps S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke Stroke, October 1, 1997; 28(10): 1956 - 1960. [Abstract] [Full Text]
|
|
|
|
|
|
T. Buttner, S. Weyers, T. Postert, R. Sprengelmeyer, and W. Kuhn S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction Stroke, October 1, 1997; 28(10): 1961 - 1965. [Abstract] [Full Text]
|
|